arrow
H

Hwang, Sung Hee

yildiz technical university
H指数:0
被引数:0
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of a biofunctional conductive neural scaffold based on chitosan, polycaprolactone, carvacrol and polyaniline

基于壳聚糖、聚己内酯、香荆芥酚和聚苯胺的生物功能导电神经支架的制备

2025-11-010
PRE
Dual acting inhibitor of soluble epoxide hydrolase and Cyclooxygenase-2, attenuates glomerular injury in renal hypoplasia mice

可溶性环氧合酶水解酶和环氧化酶-2的双效抑制剂,可减轻肾发育不全小鼠的肾小球损伤

2025-09-120
PREAI
Inhibition of soluble epoxide hydrolase in endotoxin induced pig lung injury

内毒素诱导的猪肺损伤中可溶性环氧水解酶的抑制

2025-09-100
OAAI
Coamorphous Solid Dispersion of a Soluble Epoxide Hydrolase Inhibitor t-TUCB with Amino Acid L-Arginine

可溶性环氧合酶抑制剂t-TUCB与氨基酸L-Arginine形成的共形态固体分散体

2025-05-210
PRE
Inhibition of soluble epoxide hydrolase confers neuroprotection and restores microglial homeostasis in a tauopathy mouse model

抑制可溶性环氧合酶水解酶可提供神经保护作用,并在tau病小鼠模型中恢复小胶质细胞的稳态。

2025-04-230
OA
A Soluble Epoxide Hydrolase Inhibitor Improves Cerebrovascular Dysfunction, Neuroinflammation, Amyloid Burden, and Cognitive Impairments in the hAPP/PS1 TgF344-AD Rat Model of Alzheimer's Disease

一种可溶性环氧合酶水解酶抑制剂可改善hAPP/PS1 TgF344-AD大鼠模型中阿尔茨海默病的相关脑血管功能障碍、神经炎症、淀粉样蛋白负荷和认知障碍。

2025-03-081
OA
Inhibitors of soluble epoxide hydrolase and cGAS/STING repair defects in amyloid-β clearance underlying vascular complications of Alzheimer's disease
2025-02-170
PRE
Inhibition of soluble epoxide hydrolase ameliorates cerebral blood flow autoregulation and cognition in alzheimer's disease and diabetes-related dementia rat models
2025-02-040
OA
Inhibition of Soluble Epoxide Hydrolase Reduces Inflammation and Myocardial Injury in Arrhythmogenic Cardiomyopathy

可溶性环氧合酶水解酶的抑制可减轻心律失常性心肌病中的炎症和心肌损伤

2025-02-011
OAAI
Metabolomics reveals soluble epoxide hydrolase as a therapeutic target for high- sucrose diet- mediated gut barrier dysfunction
2024-11-180
OAAI
Randomized, double-blind, phase 1a single-ascending dose and food effect studies assessing safety and pharmacokinetics of EC5026 in healthy volunteers
2024-09-193
OAAI
Dual COX-2/sEH inhibition enhances immunotherapy and chemotherapy to induce bladder cancer regression
2024-03-220
PRE
Enhancing cancer immunotherapy via inhibition of soluble epoxide hydrolase
2024-02-085
OAAI
Synthesis and Preclinical Evaluation of 22-[18F]Fluorodocosahexaenoic Acid as a Positron Emission Tomography Probe for Monitoring Brain Docosahexaenoic Acid Uptake Kinetics
2023-12-043
OAAI
Quantification of soluble epoxide hydrolase inhibitors in experimental and clinical samples using the nanobody-based ELISA

使用基于纳米抗体的ELISA定量实验和临床样品中的可溶性环氧化物水解酶抑制剂

2023-09-015
OAAI
Therapy of autoimmune inflammation in sporadic amyotrophic lateral sclerosis: Dimethyl fumarate and H-151 downregulate inflammatory cytokines in the cGAS-STING pathway
2023-07-1214
OA
Effects of chronic secondhand smoke exposure on cardiovascular regulation and the role of soluble epoxide hydrolase in mice
2023-06-081
OAAI
Inhibition of soluble epoxide hydrolase reduces paraquat neurotoxicity in rodents
2023-03-010
OAAI
Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer

PTUPB对AKR1C3和雄激素受体轴的新型抑制作用协同恩杂鲁胺治疗晚期前列腺癌

2023-01-0310
OA
Polyunsaturated Fatty Acids Mend Macrophage Transcriptome, Glycome, and Phenotype in the Patients with Neurodegenerative Diseases, Including Alzheimer's Disease

多不饱和脂肪酸可改善包括阿尔茨海默病在内的神经退行性疾病患者的巨噬细胞转录组,糖组和表型

2023-01-033
OAAI